119 related articles for article (PubMed ID: 9620905)
41. Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients.
Khatri IA; Bhaskar KR; Lamont JT; Sajjan SU; Ho CK; Forstner J
Pediatr Res; 2003 Apr; 53(4):619-27. PubMed ID: 12612214
[TBL] [Abstract][Full Text] [Related]
42. Cystic fibrosis and other respiratory diseases of impaired mucus clearance.
Livraghi A; Randell SH
Toxicol Pathol; 2007 Jan; 35(1):116-29. PubMed ID: 17325980
[TBL] [Abstract][Full Text] [Related]
43. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis.
Sanders NN; Franckx H; De Boeck K; Haustraete J; De Smedt SC; Demeester J
Thorax; 2006 Nov; 61(11):962-8. PubMed ID: 17071834
[TBL] [Abstract][Full Text] [Related]
44. DNA quantification and fragmentation in sputum after inhalation of recombinant human deoxyribonuclease.
Riethmueller J; Vonthein R; Borth-Bruhns T; Grassmé H; Eyrich M; Schilbach K; Stern M; Gulbins E
Cell Physiol Biochem; 2008; 22(1-4):347-52. PubMed ID: 18769062
[TBL] [Abstract][Full Text] [Related]
45. Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action.
Rubin BK; Ramirez O; Zayas JG; Finegan B; King M
Am Rev Respir Dis; 1992 Mar; 145(3):545-7. PubMed ID: 1546833
[TBL] [Abstract][Full Text] [Related]
46. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
47. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
van der Giessen LJ; Gosselink R; Hop WC; Tiddens HA
Eur Respir J; 2007 Oct; 30(4):763-8. PubMed ID: 17596273
[TBL] [Abstract][Full Text] [Related]
48. Numerical and experimental investigation of mucociliary clearance breakdown in cystic fibrosis.
Chatelin R; Anne-Archard D; Murris-Espin M; Thiriet M; Poncet P
J Biomech; 2017 Feb; 53():56-63. PubMed ID: 28117099
[TBL] [Abstract][Full Text] [Related]
49. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
Wilmott RW; Amin RS; Colin AA; DeVault A; Dozor AJ; Eigen H; Johnson C; Lester LA; McCoy K; McKean LP; Moss R; Nash ML; Jue CP; Regelmann W; Stokes DC; Fuchs HJ
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
[TBL] [Abstract][Full Text] [Related]
50. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa.
Laube BL; Sharpless G; Benson J; Carson KA; Mogayzel PJ
J Pediatr; 2014 Apr; 164(4):839-45. PubMed ID: 24373575
[TBL] [Abstract][Full Text] [Related]
51. The biochemical basis of cystic fibrosis: an hypothesis based upon the polyelectrolytes of mucus.
Lewis RW
Tex Rep Biol Med; 1978; 36():33-8. PubMed ID: 725794
[TBL] [Abstract][Full Text] [Related]
52. Mucus transportability: the bovine trachea and frog palate models compared.
Wills PJ; Pritchard K; Cole PJ
Eur Respir J; 1998 Oct; 12(4):837-41. PubMed ID: 9817155
[TBL] [Abstract][Full Text] [Related]
53. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
Paul K; Rietschel E; Ballmann M; Griese M; Worlitzsch D; Shute J; Chen C; Schink T; Döring G; van Koningsbruggen S; Wahn U; Ratjen F;
Am J Respir Crit Care Med; 2004 Mar; 169(6):719-25. PubMed ID: 14684561
[TBL] [Abstract][Full Text] [Related]
54. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea.
Wills PJ; Hall RL; Chan W; Cole PJ
J Clin Invest; 1997 Jan; 99(1):9-13. PubMed ID: 9011581
[TBL] [Abstract][Full Text] [Related]
55. Short-term effects of nCPAP on nasal mucociliary clearance and mucus transportability in healthy subjects.
de Oliveira LR; Albertini Yagi CS; Figueiredo AC; Saldiva PH; Lorenzi-Filho G
Respir Med; 2006 Jan; 100(1):183-5. PubMed ID: 15907380
[TBL] [Abstract][Full Text] [Related]
56. Apparent Yield Stress of Sputum as a Relevant Biomarker in Cystic Fibrosis.
Ghanem R; Roquefort P; Ramel S; Laurent V; Haute T; Le Gall T; Aubry T; Montier T
Cells; 2021 Nov; 10(11):. PubMed ID: 34831330
[TBL] [Abstract][Full Text] [Related]
57. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
Bilton D; Robinson P; Cooper P; Gallagher CG; Kolbe J; Fox H; Jaques A; Charlton B;
Eur Respir J; 2011 Nov; 38(5):1071-80. PubMed ID: 21478216
[TBL] [Abstract][Full Text] [Related]
58. Control of mucus secretion and ion transport in airways.
Nadel JA; Davis B; Phipps RJ
Annu Rev Physiol; 1979; 41():369-81. PubMed ID: 373597
[TBL] [Abstract][Full Text] [Related]
59. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
[TBL] [Abstract][Full Text] [Related]
60. In vitro mucolytic activity of recombinant human deoxyribonuclease on equine tracheobronchial mucus.
Pietra M; Guglielmini C; Forni M; Cinotti S
Vet Rec; 2000 Nov; 147(22):627-9. PubMed ID: 11128076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
